SUBHASH MEHTA: Open Payments
NPI 1255312856 · CAPE MAY COURT HOUSE, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,186 in 32 payments from 13 companies in 2025. Trend: 2023 $1,733 · 2024 $1,450 · 2025 $1,186
Food & beverage: $1,186
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 9 | $248 |
| AstraZeneca Pharmaceuticals LP | 7 | $217 |
| Teva Pharmaceuticals USA, Inc. | 1 | $123 |
| Gilead Sciences, Inc. | 1 | $120 |
| ANI Pharmaceuticals, Inc. | 1 | $115 |
| Radius Health, Inc. | 1 | $90 |
| Novo Nordisk Inc | 2 | $87 |
| Koya Medical, Inc. | 1 | $49 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $47 |
| Lundbeck LLC | 3 | $43 |
Products named: REXULTI, BREZTRI, AUSTEDO XR, Epclusa, PURIFIED CORTROPHIN GEL, Tymlos, Wegovy, AIRSUPRA.
Industry payments across NJ — which companies pay providers there.
